Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Neidhart

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Protein Engineering|October 1, 1988
The refined crystal structure of subtilisin Carlsberg at 2.5 A resolutionD J Neidhart, G A Petsko
Cancer Immunology, Immunotherapy : CII|January 1, 1987
Phase II trial of MVE-II in metastatic malignant melanomaJ Rinehart, J LaForge, D Gochnour, et al.
Cancer Research|October 1, 1986
Phase I/II trial of human recombinant beta-interferon serine in patients with renal cell carcinomaJ Rinehart, L Malspeis, D Young, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1991
Amikacin pharmacokinetics in patients receiving high-dose cancer chemotherapyR L Davis, D Lehmann, C A Stidley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1984
A randomized trial of metoclopramide and a combination of dexamethasone and lorazepam for prevention of chemotherapy-induced vomitingM Gagen, D Gochnour, D Young, et al.
Journal of Biological Response Modifiers|June 1, 1987
Phase I/II trial of recombinant gamma-interferon in patients with renal cell carcinoma: immunologic and biologic effectsJ J Rinehart, D Young, J Laforge, et al.
American Journal of Clinical Pathology|September 1, 1989
Peripheral blood morphologic changes after high-dose antineoplastic chemotherapy and recombinant human granulocyte colony-stimulating factor administrationD P Kerrigan, A Castillo, K Foucar, et al.
Cancer Investigation|January 1, 1997
Phase 1 trial of recombinant human interleukin-1 beta (rhIL-1 beta), carboplatin, and etoposide in patients with solid cancers: Southwest Oncology, Group Study 8940J Rinehart, E Hersh, B Issell, et al.
Nature|October 18, 1990
Mandelate racemase and muconate lactonizing enzyme are mechanistically distinct and structurally homologousD J Neidhart, G L Kenyon, J A Gerlt, et al.
Advances in Experimental Medicine and Biology|January 1, 1991
Inhibitor binding induces structural changes in porcine pepsinC Abad-Zapatero, T J Rydel, D J Neidhart, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Protein Engineering|October 1, 1988
The refined crystal structure of subtilisin Carlsberg at 2.5 A resolutionD J Neidhart, G A Petsko
Cancer Immunology, Immunotherapy : CII|January 1, 1987
Phase II trial of MVE-II in metastatic malignant melanomaJ Rinehart, J LaForge, D Gochnour, et al.
Cancer Research|October 1, 1986
Phase I/II trial of human recombinant beta-interferon serine in patients with renal cell carcinomaJ Rinehart, L Malspeis, D Young, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1991
Amikacin pharmacokinetics in patients receiving high-dose cancer chemotherapyR L Davis, D Lehmann, C A Stidley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1984
A randomized trial of metoclopramide and a combination of dexamethasone and lorazepam for prevention of chemotherapy-induced vomitingM Gagen, D Gochnour, D Young, et al.
Journal of Biological Response Modifiers|June 1, 1987
Phase I/II trial of recombinant gamma-interferon in patients with renal cell carcinoma: immunologic and biologic effectsJ J Rinehart, D Young, J Laforge, et al.
American Journal of Clinical Pathology|September 1, 1989
Peripheral blood morphologic changes after high-dose antineoplastic chemotherapy and recombinant human granulocyte colony-stimulating factor administrationD P Kerrigan, A Castillo, K Foucar, et al.
Cancer Investigation|January 1, 1997
Phase 1 trial of recombinant human interleukin-1 beta (rhIL-1 beta), carboplatin, and etoposide in patients with solid cancers: Southwest Oncology, Group Study 8940J Rinehart, E Hersh, B Issell, et al.
Nature|October 18, 1990
Mandelate racemase and muconate lactonizing enzyme are mechanistically distinct and structurally homologousD J Neidhart, G L Kenyon, J A Gerlt, et al.
Advances in Experimental Medicine and Biology|January 1, 1991
Inhibitor binding induces structural changes in porcine pepsinC Abad-Zapatero, T J Rydel, D J Neidhart, et al.
Pageof 3